The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


AstraZeneca steps up its Farxiga game with CV outcomes win.....           Believe it: Just as Amarin promised, Vascepa delivers big win in heart-risk study.....           Alexion eyes $500M-plus in new Soliris sales with latest rare-disease win.....           With its hepatitis C franchise tumbling, Gilead plots knockoffs of its own drugs.....           Endo presses pause on litigation after FDA assurance to sort out compounding competition by year-end.....           Allergan amps aesthetics advertising in bid to keep flagship Botox on top.....           Sanofi backs 'The 16 vaccine' campaign to bolster meningitis booster awareness.....           FiercePharmaAsia?Keytruda?s China price; Takeda?s Shire asset sale; 2nd ex-GSK scientist guilty plea.....           FDA endorses Acadia's Nuplazid after review of deaths tied to drug.....           FDA berates Chinese drugmaker tied to global valsartan recall.....           English court backs NHS in fight with Bayer, Novartis over off-label Avastin use.....           Could troubled Mylan swing a sale to private equity buyer? One analyst thinks so.....           Novartis' Alcon adds online training portal to supplement in-person eyecare education centers.....           GlaxoSmithKline fails to warn of pandemic flu vaccine?s alarming safety signal: BMJ report.....           Novartis' Alcon adds online training portal to supplement in-person eyecare education centers.....           Racing with Merck, Pfizer wins FDA 'breakthrough' tag for 20-valent pneumococcal vaccine.....           Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie.....           Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China.....           Allergan adds actor Scott Eastwood to Alzheimer's effort for even more celebrity firepower.....           Pfizer, Merck and Johnson & Johnson shifting profits to avoid billions in tax payments each year: report.....           England's cost watchdogs nix Novartis' Kymriah for adults.....           Merck follows Opdivo?s suit, prices Keytruda in China at half its U.S. tag: report.....           U.K. court invalidates Gilead's Truvada patent extension, allowing PrEP generics.....           Roche?s Tecentriq plus chemotherapy reduces death risk in lung cancer study.....           Symbiosis gets FDA approval for manufacturing fill/finish process.....           AstraZeneca?s Farxiga succeeds in phase 3 cardiovascular outcomes trial.....           FDA lifts clinical hold on Sarepta?s DMD micro-dystrophin gene therapy program.....           In kickbacks case, California insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales.....           In kickbacks case, CA insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales.....           Amgen leaves celeb spokeswoman Blythe Danner behind in newest Prolia ad.....           SEC hands Clovis $20M penalty for allegedly misleading investors.....           GlaxoSmithKline expands Canada plant, adds production of topical pain reliever.....           Novartis melanoma combination wins key thumbs-up from cost watchdog NICE after Opdivo shut out.....           Johnson & Johnson's talc supplier inks 11th-hour settlement in California mesothelioma case: report.....           AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data.....           Say hello to Sophia, Novo Nordisk's new online chatbot, available 24/7 for diabetes questions.....           In kickbacks case, CA insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales.....           Novartis plans to file for new Lucentis indication in ROP.....           Lonza adds two new Ibex solutions offerings to Swiss biopark.....           CHMP issues positive opinion supporting Trelegy Ellipta?s use in broader group of COPD patients.....           OBI Pharma?s OBI-3424 gets FDA orphan drug status to treat ALL.....           Mylan, Fujifilm Kyowa get EC nod for Humira biosimilar Hulio.....           Opiant signs contract with BARDA to accelerate OPTN003 product development.....           SIA introduces new service for pharmaceutical and healthcare shipments.....           With EpiPen competitors bearing down, can Mylan maintain its lead?.....           Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production; Merck not as lucky.....           Scientists weigh Zika vaccine challenge study after case count plummets: report.....           Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy.....           Sanofi, Regeneron pad Dupixent?s case in adolescent eczema ahead of key asthma decision.....           Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO.....           With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?.....           Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production, Merck not as lucky.....           Astellas waltzes into second season sponsorship of ABC?s ?Dancing with the Stars?.....           House quashes Senate amendment to force drug price inclusion in pharma TV ads.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
 
 
Latest news

Professional recognition for Pharmaceutical Science Degrees

The Academy of Pharmaceutical Sciences (APS) is delighted to announce that the pharmaceutical science course at the University of Greenwich has become the first APS accredited course having successfully completed the accreditation process set up by the Academy towards the end of 2017.

This is the first time that a pharmaceutical science course has been accredited in the United Kingdom and it is also, we believe, a world first.

Achieving accreditation gives assurance to students and employers that the course meets the high standards required by the Academy and that these standards will be maintained throughout the 5-year period of accreditation.

APS believes that the accreditation process will raise the profile of pharmaceutical sciences in both academia and industry. The discipline is key in the discovery, development and manufacture of new medicines and as such is central to government initiatives to encourage the pharmaceutical industry to maintain and strengthen its strong base here in the UK.

The Academy will continue to work with other stakeholders to build the science base for the ultimate benefit of patients.

 
 
APS events overview

The APS has developed an exciting and informative programme for our events in 2018.

Donít forget to make a note of APS@FIP, linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference.

Please take a look at our programme, with event summaries, below:

"5 Years of progress in Oral Biopharmaceutics - IMI OrBiTo project and global biopharmaceutics research"
17 September 2018 - AstraZeneca, Granta Park, Cambridge
The APS is pleased to announce this exciting 2 day meeting to review the progress and advances made by the collaborative IMI OrBiTo project . The OrBiTo project started in October 2012 and following a twelve-month non-cost extension phase will finish in October 2018.
Meeting sold out! To learn more, click here

OTHER EVENTS IN DEVELOPMENT
Industrial Insights 2019
Developability for Biologicals
Inhaled Workshop
3D Printing meeting
Basic Biopharmaceutics workshop 

Follow us
 
Upcoming Events
8th Annual MIBio Conference
15 November 2018
APS Additive Manufacturing Symposium
27 March 2019
APS Developability Workshop
17 - 18 April 2019
APS Industrial Insights 2019
25 - 26 April 2019
10th APS International PharmSci conference 2019
11 - 13 September 2019
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351, Fax: 0116 274 7365, Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.

Privacy Policy:
For details on the data we collect and how we store and process your data please refer to our Privacy Policy.